Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited setting

Background: There are several instances where nevirapine pharmacokinetic monitoring may be useful, such as in special populations or pharmacokinetic drug interaction studies that require the ascertainment of nevirapine pharmacokinetics in the sub-Saharan region. Objectives: The main aim of this stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Faithful Makita-Chingombe (Author), Andrew J. Ocque (Author), Robin DiFrancesco (Author), Charles Maponga (Author), Farai Muzambi (Author), Tsitsi G. Monera-Penduka (Author), Tinashe Mudzviti (Author), Takudzwa J. Mtisi (Author), Gene D. Morse (Author)
Format: Book
Published: AOSIS, 2019-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_31a2637a4ea144c58d4fb8f8d79e9c3c
042 |a dc 
100 1 0 |a Faithful Makita-Chingombe  |e author 
700 1 0 |a Andrew J. Ocque  |e author 
700 1 0 |a Robin DiFrancesco  |e author 
700 1 0 |a Charles Maponga  |e author 
700 1 0 |a Farai Muzambi  |e author 
700 1 0 |a Tsitsi G. Monera-Penduka  |e author 
700 1 0 |a Tinashe Mudzviti  |e author 
700 1 0 |a Takudzwa J. Mtisi  |e author 
700 1 0 |a Gene D. Morse  |e author 
245 0 0 |a Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited setting 
260 |b AOSIS,   |c 2019-05-01T00:00:00Z. 
500 |a 2225-2002 
500 |a 2225-2010 
500 |a 10.4102/ajlm.v8i1.880 
520 |a Background: There are several instances where nevirapine pharmacokinetic monitoring may be useful, such as in special populations or pharmacokinetic drug interaction studies that require the ascertainment of nevirapine pharmacokinetics in the sub-Saharan region. Objectives: The main aim of this study was to produce a validated, sustainable and relevant nevirapine assay method that meets bio-analytical regulatory requirements. Methods: The developed method utilised a Waters 2795 Alliance high performance liquid chromatography system with a 2996 photo diode array detector, an Atlantis dC18 5 micron, 3.9 mm × 150 mm analytical column and a gradient flow rate of 1 mL/min. Ultraviolet detection data were collected from 210 nm to 400 nm, extracted at 260 nm, and processed for nevirapine and internal standard peak height responses. Results: The method proved to be linear (R2 0.995), precise (+1.92% - +9.69%) and accurate (-9.70% - 12.0%). Recovery for the analyte and internal standard was between 98.8% and 114%. The method showed good specificity as no interferences were caused by common African traditional medicines, anti-tuberculosis medications or other concomitant antiretrovirals nor endogenous components. Conclusion: The method is reproducible, relevant to our setting and uses considerably low plasma volumes with preservation of some consumables, a desirable key factor in a resource-limited setting. 
546 |a EN 
690 |a high performance liquid chromatography 
690 |a nevirapine determination 
690 |a method development and validation 
690 |a Public aspects of medicine 
690 |a RA1-1270 
690 |a Medicine (General) 
690 |a R5-920 
655 7 |a article  |2 local 
786 0 |n African Journal of Laboratory Medicine, Vol 8, Iss 1, Pp e1-e7 (2019) 
787 0 |n https://ajlmonline.org/index.php/ajlm/article/view/880 
787 0 |n https://doaj.org/toc/2225-2002 
787 0 |n https://doaj.org/toc/2225-2010 
856 4 1 |u https://doaj.org/article/31a2637a4ea144c58d4fb8f8d79e9c3c  |z Connect to this object online.